SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________
SCHEDULE 13G
Information Statement pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Final Amendment)
American Oncology Resources, Inc.
_________________________________________________________________
(Name of Issuer)
Common Stock, $.01 par value
_________________________________________________________________
(Title of Class of Securities)
028910107
_________________________________________________________________
(CUSIP Number)
______________________________
<PAGE>
CUSIP No. 028910107 Page 2 of 5 Pages
_________________________________________________________________
1) Name of Reporting Person Welsh, Carson,
S.S. or I.R.S. Identification Anderson & Stowe
No. of Above Person V, L.P.
_________________________________________________________________
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
_________________________________________________________________
3) SEC Use Only
_________________________________________________________________
4) Citizenship or Place Delaware
of Organization
_________________________________________________________________
Number of Shares 5) Sole Voting 1,452,154 shares of
Beneficially Power Common Stock, $.01
Owned by Each par value ("Common
Reporting Person Stock")
With: ________________________________________
6) Shared Voting
Power -0-
________________________________________
7) Sole Disposi- 1,452,154 shares of
tive Power Common Stock
________________________________________
8) Shared Dis-
positive Power -0-
________________________________________
9) Aggregate Amount Beneficially 1,452,154 shares of
Owned by Each Reporting Person Common Stock
_________________________________________________________________
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
_________________________________________________________________
11) Percent of Class
Represented by 4.9%
Amount in Row (9)
_________________________________________________________________
12) Type of Reporting
Person PN
<PAGE>
CUSIP No. 028910107 Page 3 of 5 Pages
_________________________________________________________________
1) Name of Reporting Person WCAS Healthcare
S.S. or I.R.S. Identification Partners, L.P.
No. of Above Person
_________________________________________________________________
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
_________________________________________________________________
3) SEC Use Only
_________________________________________________________________
4) Citizenship or Place Delaware
of Organization
_________________________________________________________________
Number of Shares 5) Sole Voting -0-
Beneficially Power
Owned by Each
Reporting Person
With: ________________________________________
6) Shared Voting
Power -0-
________________________________________
7) Sole Disposi- -0-
tive Power
________________________________________
8) Shared Dis-
positive Power -0-
________________________________________
9) Aggregate Amount Beneficially -0-
Owned by Each Reporting Person
_________________________________________________________________
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
_________________________________________________________________
11) Percent of Class
Represented by -0-
Amount in Row (9)
_________________________________________________________________
12) Type of Reporting
Person PN
<PAGE>
CUSIP No. 028910107 Page 4 of 5 Pages
Final Amendment to Schedule 13G
_______________________________
Reference is hereby made to the statement on Schedule
13G originally filed with the Securities and Exchange Commission
on January 29, 1996 and Amendment No. 1 thereto filed on February
12, 1997 (as so amended, the "Schedule 13G"). Terms defined in
the Schedule 13G are used herein as so defined.
The Schedule 13G is hereby amended as follows:
Item 1(b) - Address of Issuer's Principal Executive Offices:
16825 Northchase Drive, Suite 1300
Houston, TX 77060
Item 4 - Ownership.
(a) Amount Beneficially Owned:
WCAS V: 1,452,154 shares of Common Stock
Healthcare Partners: -0-
(b) Percent of Class:
WCAS V: 4.9%
Healthcare Partners: -0-
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
WCAS V: 1,452,154
Healthcare Partners: -0-
(ii) shared power to vote or to direct the vote:
-0-
(iii) sole power to dispose or to direct the
disposition of:
WCAS V: 1,452,154
Healthcare Partners: -0-
(iv) shared power to dispose or to direct the
disposition of: -0-
Item 5 - Ownership of Five Percent or Less of a Class:
This statement is being filed to report that as of
the date hereof the Reporting Persons have ceased to be the
beneficial owners of more than five percent of the Common Stock.
<PAGE>
CUSIP No. 028910107 Page 5 of 5 Pages
Signature:
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in
this statement is true, complete and correct.
WELSH, CARSON, ANDERSON & STOWE V, L.P.
By: WCAS V Partners, General Partner
By /s/ Laura VanBuren
General Partner
WCAS HEALTHCARE PARTNERS, L.P.
By: WCAS HP Partners, General Partner
By /s/ Russell L. Carson
General Partner
Dated: February 10, 1998
